Artwork
iconShare
 
Manage episode 390484329 series 2781330
Content provided by Magellan Asset Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Magellan Asset Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this special 15 minute episode of Magellan In The Know, Portfolio Manager Nikki Thomas is joined by Investment Analyst Wilson Nghe, providing an update on GLP-1 following our recent episode on the weight loss wonder drug. Recently returned from the US, Wilson spoke with commercial players and policy makers on how they will approach reimbursements, which could be one of the biggest drivers to accelerate demand. They also discuss the future of care delivery in the US healthcare system.

Listen below to the full episode

Ep. 40 The weight loss drug shaping-up as a gamechanger

  continue reading

64 episodes